Do Interventions to Reduce Coronary Heart Disease Reduce the Incidence of Type 2 Diabetes? A Possible Role for Inflammatory Factors
Author(s) -
Steven M. Haffner
Publication year - 2001
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.103.3.346
Subject(s) - medicine , diabetes mellitus , type 2 diabetes , incidence (geometry) , psychological intervention , myocardial infarction , case fatality rate , epidemiology , endocrinology , physics , psychiatry , optics
Type 2 diabetes is as a major cause of coronary heart disease (CHD). In some studies, the rate of CHD in type 2 diabetic subjects approaches that observed in some subjects with prevalent CHD.1 Additionally, the case fatality rate of CHD is increased in type 2 diabetics.2 In one Finnish study, 50% of diabetic men who had a first coronary heart event died within a year of their initial presentation; 50% of these fatal cases died before they reached the hospital (“sudden death”). These subjects, by definition, could not benefit from a secondary prevention program.2 Clearly, preventing type 2 diabetes would be important in the reduction of CHD. The Diabetes Prevention Program3 is a large National Institutes of Health–funded trial to prevent diabetes in subjects with impaired glucose tolerance. The interventions being tested are metformin and intensive lifestyle changes. Recently, the Finnish Diabetes Prevention Program reported a 58% reduction in the incidence of type 2 diabetes in 523 subjects with impaired glucose tolerance (American Diabetes Association, personal communication, June 2000).Approaches to reduce CHD have focused on the benefits of lowering LDL cholesterol with HMG CoA reductase inhibitors (statins)4 …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom